Products for Research Use Only

8-Br-dGTP (sodium)

CAT: 0804-HY-134273ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-134273ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
8-Br-dGTP (8-Bromo-dGTP) sodium (Compound 5), an 8-brominated purine nucleotide, is a syn-oriented analog of dGTP. 8-Br-dGTP sodium can be hydrolyzed by the enzyme hMTH1 protein. 8-Br-dGTP sodium inhibits dGTP-activated ADP reduction with a Ki of 56 μM. 8-Br-dGTP sodium has no significant genotoxicity and mutagenic potentials during DNA synthesis[1][2][3].
Product Name Alternative
8-Bromo-dGTP (sodium)
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Smiles
O[C@H]1C[C@H](N2C(Br)=NC3=C2NC(N)=NC3=O)O[C@@H]1COP(OP(OP(O[Na])(O[Na])=O)(O[Na])=O)(O[Na])=O
Molecular Formula
C10H11BrN5Na4O13P3
Molecular Weight
674.00
References & Citations
[1]Kamiya H, et al. Probing the substrate recognition mechanism of the human MTH1 protein by nucleotide analogs. J Mol Biol. 2004 Feb 27;336 (4) :843-50. |[2]Yin Y, et al. Effects of 8-halo-7-deaza-2'-deoxyguanosine triphosphate on DNA synthesis by DNA polymerases and cell proliferation. Bioorg Med Chem. 2016 Aug 15;24 (16) :3856-61. |[3]Wu X, et al. Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase. Bioorg Med Chem Lett. 2000 Oct 16;10 (20) :2387-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported